MIRM logo

Mirum Pharmaceuticals, Inc. (MIRM) Cash from operations

annual CFO:

$10.32M+$81.27M(+114.55%)
December 31, 2024

Summary

  • As of today (September 16, 2025), MIRM annual cash flow from operations is $10.32 million, with the most recent change of +$81.27 million (+114.55%) on December 31, 2024.
  • During the last 3 years, MIRM annual CFO has risen by +$143.08 million (+107.78%).
  • MIRM annual CFO is now at all-time high.

Performance

MIRM Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMIRMcash flow metrics

quarterly CFO:

$12.04M+$14.00M(+713.97%)
June 30, 2025

Summary

  • As of today (September 16, 2025), MIRM quarterly cash flow from operations is $12.04 million, with the most recent change of +$14.00 million (+713.97%) on June 30, 2025.
  • Over the past year, MIRM quarterly CFO has increased by +$15.84 million (+416.59%).
  • MIRM quarterly CFO is now -20.85% below its all-time high of $15.21 million, reached on March 31, 2024.

Performance

MIRM quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMIRMcash flow metrics

TTM CFO:

$8.99M+$15.84M(+231.35%)
June 30, 2025

Summary

  • As of today (September 16, 2025), MIRM TTM cash flow from operations is $8.99 million, with the most recent change of +$15.84 million (+231.35%) on June 30, 2025.
  • Over the past year, MIRM TTM CFO has increased by +$32.42 million (+138.39%).
  • MIRM TTM CFO is now -12.88% below its all-time high of $10.32 million, reached on December 31, 2024.

Performance

MIRM TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMIRMcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

MIRM Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+114.5%+416.6%+138.4%
3 y3 years+107.8%+159.7%+107.1%
5 y5 years+126.2%+170.8%+114.0%

MIRM Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+107.8%-20.9%+135.1%-12.9%+107.1%
5 y5-yearat high+107.8%-20.9%+129.9%-12.9%+106.1%
alltimeall timeat high+107.8%-20.9%+129.9%-12.9%+106.1%

MIRM Cash from operations History

DateAnnualQuarterlyTTM
Jun 2025
-
$12.04M(-714.0%)
$8.99M(-231.4%)
Mar 2025
-
-$1.96M(-61.3%)
-$6.85M(-166.3%)
Dec 2024
$10.32M(-114.6%)
-$5.07M(-227.2%)
$10.32M(-942.9%)
Sep 2024
-
$3.98M(-204.8%)
-$1.23M(-94.8%)
Jun 2024
-
-$3.80M(-125.0%)
-$23.43M(+6.7%)
Mar 2024
-
$15.21M(-191.5%)
-$21.96M(-69.0%)
Dec 2023
-$70.94M(-40.9%)
-$16.62M(-8.8%)
-$70.94M(-19.9%)
Sep 2023
-
-$18.22M(+681.7%)
-$88.60M(-8.1%)
Jun 2023
-
-$2.33M(-93.1%)
-$96.40M(-15.6%)
Mar 2023
-
-$33.77M(-1.4%)
-$114.24M(-4.9%)
Dec 2022
-$120.14M
-$34.27M(+31.7%)
-$120.14M(+0.9%)
Sep 2022
-
-$26.02M(+29.0%)
-$119.01M(-6.4%)
Jun 2022
-
-$20.17M(-49.1%)
-$127.19M(-13.6%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$39.67M(+19.7%)
-$147.22M(+10.9%)
Dec 2021
-$132.76M(+49.0%)
-$33.15M(-3.1%)
-$132.76M(-2.3%)
Sep 2021
-
-$34.20M(-14.9%)
-$135.89M(+14.1%)
Jun 2021
-
-$40.20M(+59.5%)
-$119.14M(+24.2%)
Mar 2021
-
-$25.21M(-30.5%)
-$95.93M(+7.7%)
Dec 2020
-$89.08M(+126.3%)
-$36.28M(+107.9%)
-$89.08M(+34.0%)
Sep 2020
-
-$17.45M(+2.7%)
-$66.49M(+3.5%)
Jun 2020
-
-$16.99M(-7.4%)
-$64.26M(+16.2%)
Mar 2020
-
-$18.35M(+34.0%)
-$55.29M(+40.5%)
Dec 2019
-$39.36M(>+9900.0%)
-$13.70M(-10.0%)
-$39.36M(+53.4%)
Sep 2019
-
-$15.22M(+89.9%)
-$25.66M(+145.8%)
Jun 2019
-
-$8.02M(+230.5%)
-$10.44M(+330.5%)
Mar 2019
-
-$2.43M
-$2.43M
Dec 2018
-$373.00K
-
-

FAQ

  • What is Mirum Pharmaceuticals, Inc. annual cash flow from operations?
  • What is the all time high annual CFO for Mirum Pharmaceuticals, Inc.?
  • What is Mirum Pharmaceuticals, Inc. annual CFO year-on-year change?
  • What is Mirum Pharmaceuticals, Inc. quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Mirum Pharmaceuticals, Inc.?
  • What is Mirum Pharmaceuticals, Inc. quarterly CFO year-on-year change?
  • What is Mirum Pharmaceuticals, Inc. TTM cash flow from operations?
  • What is the all time high TTM CFO for Mirum Pharmaceuticals, Inc.?
  • What is Mirum Pharmaceuticals, Inc. TTM CFO year-on-year change?

What is Mirum Pharmaceuticals, Inc. annual cash flow from operations?

The current annual CFO of MIRM is $10.32M

What is the all time high annual CFO for Mirum Pharmaceuticals, Inc.?

Mirum Pharmaceuticals, Inc. all-time high annual cash flow from operations is $10.32M

What is Mirum Pharmaceuticals, Inc. annual CFO year-on-year change?

Over the past year, MIRM annual cash flow from operations has changed by +$81.27M (+114.55%)

What is Mirum Pharmaceuticals, Inc. quarterly cash flow from operations?

The current quarterly CFO of MIRM is $12.04M

What is the all time high quarterly CFO for Mirum Pharmaceuticals, Inc.?

Mirum Pharmaceuticals, Inc. all-time high quarterly cash flow from operations is $15.21M

What is Mirum Pharmaceuticals, Inc. quarterly CFO year-on-year change?

Over the past year, MIRM quarterly cash flow from operations has changed by +$15.84M (+416.59%)

What is Mirum Pharmaceuticals, Inc. TTM cash flow from operations?

The current TTM CFO of MIRM is $8.99M

What is the all time high TTM CFO for Mirum Pharmaceuticals, Inc.?

Mirum Pharmaceuticals, Inc. all-time high TTM cash flow from operations is $10.32M

What is Mirum Pharmaceuticals, Inc. TTM CFO year-on-year change?

Over the past year, MIRM TTM cash flow from operations has changed by +$32.42M (+138.39%)
On this page